You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (8)

Journals (0)

1-8 of 8 results for rozanolixizumab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis

Retricted access

Review article

First published 2024-11

Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis

Emily M. Hitt

Annals of Pharmacotherapy

Select article: Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report

Retricted access

Case report

First published 2025

Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report

Hamza Maqsood, James Fleming

The Neurohospitalist

Select article: Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

Open access

Research article

First published 2025-3

Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

Ali A Habib, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Select article: Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,double-blind,placebo-controlled,adaptive phase III MycarinG study

Open access

Research article

First published 2024

Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,double-blind,placebo-controlled,adaptive phase III MycarinG study

Ali A. Habib, Sabrina Sacconi, Giovanni Antonini [...]

Therapeutic Advances in Neurological Disorders

Select article: Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Open access

Research article

First published 2025-3

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Vera Bril, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Select article: The importance of FcRn in neuro-immunotherapies: From IgG catabolism,FCGRT gene polymorphisms,IVIg dosing and efficiency to specific FcRn inhibitors

Open access

Review article

First published 2021

The importance of FcRn in neuro-immunotherapies: From IgG catabolism,FCGRT gene polymorphisms,IVIg dosing and efficiency to specific FcRn inhibitors

Marinos C. Dalakas, Peter J. Spaeth

Therapeutic Advances in Neurological Disorders

Select article: Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Open access

Research article

First published 2025

Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Muriel Schraad, Mathias Mäurer, Anke Salmen [...]

Therapeutic Advances in Neurological Disorders

Select article: Reporting on Adverse Clinical Events

Retricted access

Research article

First published 2025-5

Reporting on Adverse Clinical Events

Clin-Alert

1
10 / page

Article type

Publication date

Subjects

Access